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Introduction
Clustered regularly interspaced short palindromic repeats 
(CRISPRs) are a prokaryotic mechanism for preventing hori-
zontal gene transfer (HGT) and infection by mobile genetic ele-
ments.1-3 The CRISPR array consists of identical repeats separated 
by short “spacers” derived from previously encountered foreign 
genetic elements.4-7 Linked to the CRISPR array are CRISPR-
associated (cas) genes, which encode the proteins that mediate 
the CRISPR response to the insertion of foreign double-stranded 
DNA (dsDNA) or single-stranded RNA (ssRNA) into the cell.8-
10 The response can be divided into three stages: adaptation, the 
integration of new spacers into the CRISPR array; expression, 
the transcription of the array and processing of the transcript to 
short, mature CRISPR RNAs (crRNA); interference, the recog-
nition and degradation of foreign dsDNA or ssRNA.
cas genes are arranged in loci, which can be classified into one 
of three main systems (types I, II and III) based on the identity 
and order of genes in the locus.10 The CRISPR/Cas systems can 
be further subdivided into a total of 10 subtypes (Fig. S1), all of 
The cascade complex for cRIspR-mediated antiviral immunity uses cRIspR RNA (crRNA) to target invading DNA species 
from mobile elements such as viruses, leading to their destruction. The core of the cascade effector complex consists 
of the cas5 and cas7 subunits, which are widely conserved in prokaryotes. cas7 binds crRNA and forms the helical 
backbone of cascade. Many archaea encode a version of the cascade complex (denoted Type I-A) that includes a csa5 
(or small) subunit, which interacts weakly with the core proteins. here, we report the crystal structure of the csa5 protein 
from Sulfolobus solfataricus. csa5 comprises a conserved α-helical domain with a small insertion consisting of a weakly 
conserved β-strand domain. In the crystal, the csa5 monomers have multimerized into infinite helical threads. At each 
interface is a strictly conserved intersubunit salt bridge, deletion of which disrupts multimerization. structural analysis 
indicates a shared evolutionary history among the small subunits of the cRIspR effector complexes. The same α-helical 
domain is found in the c-terminal domain of cse2 (from Type I-e cascade), while the N-terminal domain of cse2 is found in 
cmr5 of the cMR (Type III-B) effector complex. As cmr5 shares no match with csa5, two possibilities present themselves: 
selective domain loss from an ancestral cse2 to create two new subfamilies or domain fusion of two separate families 
to create a new cse2 family. A definitive answer awaits structural studies of further small subunits from other cRIspR 
effector complexes.
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which, except type III-B, target dsDNA.11-13 Uniquely type III-B 
targets ssRNA.14,15 The type I interference complex is known as 
the CRISPR-associated complex for antiviral defense (Cascade). 
The exemplar is the type I-E complex (eCascade) from E. 
coli,13 which consists of Cas5, Cas6e, Cas7, Cse1 and Cse2 in 
a 1:1:6:1:2 stoichiometry with the six Cas7 subunits forming a 
central helical spine to which crRNA and all the other subunits 
bind.16 This topology appears to be conserved in the type I-C and 
I-F systems.17,18
Significantly less is known about the effector complex of type 
I-A systems (aCascade, also known as the archaeal Cascade), 
which consists of Cas5, Cas7, Csa5 and in some systems Cas8a1 
or Cas8a2. It has not yet been possible to purify a full aCas-
cade complex; the Sulfolobus solfataricus (Sso) aCascade partly 
dissociates during purification,19 while the Thermoproteus tenax 
complex is insoluble after overexpression, with minimal soluble 
material after refolding.20 Only a stable core complex of Cas5 
and Cas7 remains after the partial dissociation of Sso aCascade. 
The Cas5/Cas7 complex forms helical oligomers reminiscent of 
the Cas7 backbone of eCascade. Interestingly this core complex 
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by the genes sso1398-1400 and sso1441-1443 
(Fig. 1A). The two Csa5 paralogs share 11% 
sequence identity. Experiments described 
here utilize the Sso1441-1443 proteins unless 
otherwise indicated. Immunoprecipitation 
of the Cas5/Cas7 core complex from S. sol-
fataricus cell lysates using affinity-purified 
antibodies raised against the recombinant 
complex co-precipitated small amounts of 
Csa5 (Fig. 1B). The reciprocal experiment 
using antibodies against Csa5 pulled down 
both Cas5 and Cas7. The small amounts 
that are co-immunoprecipitated are indica-
tive of a weak interaction between Csa5 
and Cas5/Cas7, consistent with the disso-
ciation of Csa5 from the complex during 
purification.19
Lintner et al.19 showed that cellular Cas5/
Cas7 (Sso1441-1442) bound to crRNA, 
raising the possibility that Csa5 only binds 
to Cas5/Cas7 in the presence of crRNA. 
Fluorescently labeled oligonucleotides were 
used for fluorescence anisotropy experiments 
to determine interactions between Cas5/Cas7 
and Csa5. Consistent with previous stud-
ies,19 the Cas5/Cas7 complex bound to fluo-
rescently labeled crRNA with a dissociation 
constant (K
D
) of 1.38 ± 0.14 μM (Fig. 2A). 
However, Csa5 itself did not form a stable 
interaction with crRNA, ssDNA or a hetero-
duplex formed from crRNA and ssDNA con-
taining a protospacer in vitro (Fig. 2B), nor 
did we observe convincing evidence for bind-
ing to a pre-formed complex of Cas5/Cas7/
crRNA (Fig. 2C).
The crystal structure of Csa5. The lim-
ited solubility of Csa5 encoded by Sso1443 
hindered its crystallization and so its paralog, Sso1398, was 
crystallized. The structure was solved using a selenomethio-
nyl variant with diffraction recorded to a resolution of 2.7 Å 
(Fig. 3A and Table 1). The asymmetric unit (ASU) containes 
nine monomers and each protein monomer is constructed 
of two domains, denoted α and β (Fig. 3B). The α-domain 
is an all α-helical arrangement consisting of α
1
-α
4
, formed by 
residues 5–64 and α
6
 and α
7
 formed by residues 130–162. The 
β-domain is formed by residues 65–129 and is an insertion 
between α
4
 and α
6
. The β-domain contains a single helix (α
5
) 
and six β-strands (β
1
-β
6
) arranged as three anti-parallel two-
stranded β-sheets (Fig. 3A). Residues 1–4 were disordered in 
all monomers; the loops connecting β
1
-β
2
 and β
5
-β
6
 were disor-
dered in some monomers. The residues that are conserved across 
the Csa5 family are located in the α-domain, although the short 
β
6
 strand may show some conservation (Fig. S2). The β-domain 
insertions of Csa5 homologs vary in length from 20–67 residues 
and show minimal sequence conservation, even between closely 
related strains (Fig. S2).
is capable of binding crRNA and a heteroduplex formed from 
crRNA and protospacer, a mimic of the R-loop structure formed 
during interference.19 Csa5 has been shown to interact with this 
complex, though its role within aCascade is unknown.19
The genome of S. solfataricus encodes three possible aCascade 
complexes as well as one CSM complex and three CMR com-
plexes.21 Here, we report the crystal structure and initial func-
tional characterization of the archaeal-specific Cascade subunit 
Csa5. Structural homology shows that Csa5 and Cse2, a subunit 
of eCascade, have one domain in common. In addition, the sec-
ond domain of Cse2 is shown to have a fold related to the small 
subunit (Cmr5) of the archaeal type III-B system. Altogether, 
these observations highlight the conservation of structural ele-
ments in diverse CRISPR effector complexes.
Results
Csa5 interacts with the Cas5/Cas7 complex. The two copies 
of S. solfataricus aCascade studied in this paper are encoded 
Figure 1. Gene organization and protein interactions of archaeal cascade subunits. (A) 
Two of the type I-A cas loci from S. solfataricus showing the gene numbers and families. (B) 
co-immunopreciptiation of csa5 and cas5/cas7 from S. solfataricus cell extracts. Antibodies 
raised against cas5/cas7 pull down csa5 from cell extracts (top two panels). Antibodies raised 
against csa5 pull down small amounts of cas5/cas7 from cell extracts (middle two panels). 
csa5 pre-immune complex did not pull down any of the proteins (bottom two panels). The 
marker lanes (m) contain recombinant proteins as size markers.
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respectively) (Fig. 4A), indicating that the mutant is smaller. 
The estimated weights of both native and mutant are physically 
unrealistic (26 and 6 kDa, respectively, where a monomer is 19 
kDa) and we attribute this to the unusual shape of the protein. 
Dynamic light scattering experiments showed that the mutant 
had a smaller radius of gyration than the wild-type, supporting 
the gel filtration data (Fig. 4B).
As both residues are conserved, we reasoned the salt bridge 
may be a conserved feature, so we examined the effect of the 
corresponding D32A mutation in Sso1443 (Csa5 itself). 
Recombinant wild-type Csa5 had a solubility limit of 1 mgml-1, 
whereas Csa5D32A exhibited a > 10-fold increase in solubility. 
Csa5D32A eluted from a gel filtration column consistent with a 
monomeric species, an observation independently supported by 
isothermal calorimetry (Fig. S4).
Structural homology to other Cas proteins. The structure 
of Sso1398 was compared with known structures and while the 
PDBeFold server23 did not find any significant matches, the 
DALI server24 detected homology for the α-domain while the 
β-domain does appear to be unique. The α-domain (excluding 
α
1
) matched the C-terminal domain of Cse2 from Thermus ther-
mophilus25 (PDB 2ZCA, Z score 4.5, 2.7 Å over 73 residues) and 
to a lesser extent Cse2 from Thermobifida fusca26 (PDB 4H79, 
Strikingly the nine monomers of the ASU are assembled in a 
continuous helical oligomer that, due to crystal symmetry, cre-
ates an infinite helical thread (Fig. 3B). The continuous helix has 
a pitch of 18 nm and a width of 8 nm. The crystal is composed 
of bundles of these infinite threads. Within the ASU, the nine 
monomers are essentially identical, superimposing with an aver-
age Cα rmsd of 0.21 Å. The nine interfaces within the ASU show 
subtle differences, suggesting a level of plasticity at the interface 
(Fig. S3). Analysis of the electrostatic potential of the solvent-
exposed surface does not reveal any regions of significant positive 
charge (Fig. 3C), consistent with the observed lack of binding to 
nucleic acids.
Oligomerization of Csa5 proteins. The interfacing residues 
are predominantly located in the α-domain with a few contacts 
from β
1
, β
2
 and β
6
. Analysis of the interfaces within the helices 
using the PDBe PISA server22 showed that 1100 Å2 of surface area 
from each monomer was buried within a “dimer.” The interfaces 
are hydrophilic and are scored in PISA as unstable in solution. 
In our analysis, we noted an intersubunit salt bridge between 
two conserved residues, Asp35 and Arg55 (Figs. 3D; Fig. S2). 
Disrupting this salt bridge (Sso1398D35A) led to the protein 
eluting from a calibrated gel filtration column with a larger reten-
tion volume than the wild-type protein (16.4 ml and 13.9 ml, 
Figure 2. Analysis of the interactions of acascade with nucleic acids using fluorescence anisotropy. (A) The average change in anisotropy upon bind-
ing of the cas5/cas7 complex to fluorescent crRNA. experiments were performed in triplicate and error bars represent the standard error of the data. 
The data were fitted to a binding curve with a KD of 1.38 ± 0.14 μM (error estimated from curve fitting). (B) csa5 does not interact with crRNA, ssDNA or 
a heteroduplex of crRNA and protospacer. (C) csa5 does not interact with a pre-formed complex of cas5/cas7/crRNA.
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and in Csa5 itself results in a profound change in the biophysical 
properties of the proteins. In both proteins, the mutant is smaller 
and less prone to aggregation. Since the change is seen in both 
proteins and the salt bridge is conserved, we hypothesize that the 
interface (but not the infinite threads) has a functional signifi-
cance that will be revealed when the structure of the aCascade 
complex is determined.
Cse2 forms a dimer in eCascade, which creates a positively 
charged surface for interacting with nucleic acids.16 This face is 
formed by both domains of the protein and, therefore, is only par-
tially conserved in Csa5. This surface is not significantly positively 
charged in Sso1398 or in a homology model of Csa5. Although 
Csa5 possesses a weakly positively charged face at the base of the 
α-domain (Fig. S5), the residues that form it are not well-conserved 
across the family. Cse2 itself is capable of binding both dsDNA 
and ssRNA non-specifically26 and an eCascade-crRNA complex 
lacking Cse2 shows reduced binding affinity for target plasmid 
DNA.27 It has been hypothesized that Cse2 stabilizes the R-loop 
nucleotide structure by either binding the RNA/DNA heterodu-
plex directly or indirectly by binding to non-complementary DNA 
strand. In contrast, Csa5 did not bind to any nucleic acid tested, 
including a DNA/RNA heteroduplex and ssDNA, both of which 
are present in an R-loop. Therefore, despite the structural homol-
ogy between Cse2 and Csa5, these two proteins may play different 
roles within their respective Cascade complexes.
In a recent bioinformatics study, Makarova et al. suggested 
that several small Cas proteins, which were predicted to be largely 
Z-score 2.9, 2.9 Å over 73 residues). It is also similar to the 
N-terminal domain of StySJI M, a Type I HsdM subunit from a 
restriction enzyme of Bacteroides thetaiotaomicron (PDB 2OKC, 
Z score 3.3, 2.6 Å over 68 residues); the domain itself has no 
assigned function.
Discussion
Our data show that the interaction of the Csa5 subunit with 
the core Cascade structure is below the detection limit of the 
biophysical techniques we employed. Pull-down experiments 
also point to the interaction being weak. Of course, we cannot 
exclude the possibility that additional factors such as Cas6 and/or 
the presence of target DNA are required for assembly. However, 
in general our data fit with an emerging picture that Csa5 easily 
dissociates from the aCascade complex.
The structure of the paralog Sso1398 shows a remarkable 
arrangement in the crystal. The continuous helical oligomers 
are reminiscent of the Cas7 helical backbone that appears to be 
a conserved feature of Cascade complexes.16-18 The S. solfatari-
cus Cas7 oligomer exhibits a helical pitch of 14 nm,19 which is 
broadly compatible with the Csa5 pitch of 18 nm. The helical 
threads are stabilized by a conserved pair of residues that form 
an intersubunit salt bridge. The absolute conservation of these 
residues is striking, as only one other residue (Ala158, located in 
the hydrophobic core) is completely conserved across the Csa5 
family (Fig. S2). Mutation of the salt bridge both in the paralog 
Figure 3. The crystal structure of sso1398. (A) The sso1398 monomer consists of the α-domain (yellow) and the β-domain (purple). secondary struc-
ture elements are labeled and the N- and c-termini are shown as blue and red spheres, respectively. (B) The crystal contains chains of helical oligomers 
of sso1398, shown here across three AsUs with the molecules of one AsU shown in colors. The helical pitch and width are indicated. (C) electrostatic 
surface potential of a monomer of sso1398 calculated using ccp4MG.41 (D) close up of the box in (B). A conserved salt bridge forms at the dimer inter-
face between Asp35 (green) and Arg55 (cyan) and contributes significantly to the stability of the oligomer.
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Materials and Methods
Cloning. sso1398 was cloned into the pDEST14 plasmid29 and 
sso1443 into pET151/D-TOPO (Invitrogen) with cleavable 
N-terminal His
6
-tags. Mutations were introduced using pub-
lished30 or standard QuikChange (Stratagene) protocols. The 
oligonucleotide sequences used for cloning and mutagenesis are 
available on request.
Expression and purification. Sso1398, Sso1443 and their 
variants were expressed in C43 (DE3) E. coli in LB medium 
using 1.0 or 0.4 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG), respectively, to induce protein expression. The cultures 
were incubated at 37°C throughout (Sso1398) or 25°C (Sso1443) 
after induction and the cells harvested after overnight incuba-
tion. The selenomethionyl derivative of Sso1398 was expressed in 
B834 (DE3) E. coli grown in M9 minimal medium supplemented 
with Selenomethionine Nutrient Mix (Molecular Dimensions) 
and 50 mgL-1 (L)-selenomethionine. The expression conditions 
were as with the native protein except the cells were harvested 
after 30 h. Sso1441 and Sso1442 were co-expressed in E. coli as 
described previously.19
All proteins were purified using previously published proto-
cols.19,29 Briefly, cell pellets were resuspended and then lysed by 
sonication (MSE Soniprep) or with a cell disruptor (Constant 
Systems Ltd.). The lysate was cleared by centrifugation and 
passed over a Ni-NTA column (Qiagen). The eluted protein was 
incubated with TEV protease and then re-applied to the col-
umn before application to a Superdex S75 gel filtration column 
(GE Healthcare) equilibrated in 20 mM Tris pH 7.5, 150 mM 
NaCl (Sso1398) or 20 mM Tris pH 7.5, 500 mM NaCl, 10% 
glycerol (Sso1443). One mM β-mercaptoethanol was added to 
all buffers during purification of the selenomethionyl deriva-
tive. All proteins were concentrated to ≥ 10 mgml−1 except 
for wild-type Sso1443, which was to 1 mgml−1 due to low 
solubility.
helical, could be combined into a new family (Cas11).28 The puta-
tive Cas11 family has been proposed to comprise Csa5 (type I-A), 
Cse2 (type I-E), Csm2 (type III-A) and Cmr5 (type III-B) as well as 
the C-terminal helical domain of Cas8 (various subtypes). Crystal 
structures are now available for three of these protein families: 
Csa5 (Sso1398), Cse2 (TthCse2 and TfuCse2) and Cmr5 “T. ther-
mophilus (PDB 2ZOP)25 and Archaeoglobus fulgidus (PDB 2OEB),” 
allowing an assessment of these predictions. The α-domain of 
Sso1398 is indeed homologous to the C-terminal domain of Cse2 
(Fig. 5) but neither it nor the β-domain bears any resemblance to 
either Cmr5 structure. However, the N-terminal domain of Cse2 
is homologous to four helices of Cmr5 (Cα rmsds of 3.2 Å over 50 
residues and 3.0 Å over 60 residues to AfuCmr5 and TthCmr5, 
respectively) (Fig. 5). Sequence conservation between the struc-
tures is limited to residues of the hydrophobic core; the lack of 
conservation in exposed residues would argue against a common 
function. This is supported by the different properties of Csa5 and 
Cse2 combined with the observation that Cmr5 is not essential for 
the function of the CMR complex,15 whereas loss of Cse2 signifi-
cantly impacts the activity of eCascade.27
Analysis of the structures reveals a nuanced set of relationships 
among the small subunits. Of the two domains of Cse2, one is 
found in the Cmr5 family and the other in the Csa5 family; there 
is no structural relationship between the Cmr5 and Csa5 families. 
This is consistent with either selective loss of one or other domain 
from the ancestral Cse2 (Cas11) family during the diversifica-
tion of the CRISPR/Cas systems to form the Cmr5 and Csa5 
lineages, or alternatively a fusion of the Cmr5 and Csa5 families 
to create the Cse2 lineage as the Csa5 and Cmr5 proteins have 
nothing in common beyond a potential shared ancestor in Cse2. 
To further elucidate the evolutionary relationships between the 
so-called small subunits of the interference complexes, the struc-
ture of Csm2 would be particularly helpful, as it is a key remain-
ing missing piece. The full-length structure of Cas8 is also likely 
to be useful in firmly establishing such relationships.
Figure 4. The oligomerization of csa5. (A) Gel filtration elution profiles for sso1398WT and sso1398D35A using 2 mgml-1 protein loaded onto a 
superose 12 10/300 column. The proteins ran aberrantly on gel filtration and so the masses of the oligomers could not be accurately estimated. (B) 
Representative radius distributions of sso1398WT and sso1398D35A determined by dynamic light scattering.
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pH 8.0 and incubated at 4°C overnight. The resin was washed 
with 0.1 M NaHCO
3
 pH 8.3, 0.5 M NaCl and then 10 mM Tris 
pH 4.0 for four cycles followed by incubation with the immune 
serum in 10 mM Tris pH 7.5 at 4°C overnight. The resin was 
washed with 10 mM Tris pH 7.5 and then 10 mM Tris pH 7.5, 
0.5 M NaCl. The antibodies were eluted in two stages, the first 
of which was 100 mM glycine pH 2.5 directly into 1 M Tris pH 
8.0. The resin was further washed with 10 mM Tris pH 8.8 and 
Pull-down interactions. For the production of antibodies, 
1 mg of purified recombinant Csa5 or Cas5/Cas7 protein was 
used to raise polyclonal antibodies in sheep (Scottish National 
Blood Transfusion Service). The antibodies were affinity purified 
using cyanogen bromide-activated-Sepharose 4B resin (Sigma). 
The target protein (Cas5/Cas7 or Csa5) and resin were incubated 
overnight in 0.1 M NaHCO
3
 pH 8.3, 0.5 M NaCl at 4°C. The 
resin was washed with buffer, resuspended in 1 M ethanolamine 
Figure 5. structural homology between csa5, cse2 and cmr5. (A) The structures of Afucmr5 (pDB 2OeB, right), Tthcse2 (pDB 2ZcA, middle) and csa5 
(right). structural features conserved between cmr5 and cse2 are shown in shades of blue and between cse2 and csa5 in shades of yellow. Non-con-
served features are shown in green (cmr5), orange (cse2) and purple (csa5). (B) connector diagrams of the three proteins highlighting the conserved 
connectivity of the structural elements. (C) superposition of the conserved helices of Afucmr5, Tthcse2, Tthcmr5 (navy) and Tfucse2 (pale blue). (D) 
superposition of the conserved helices of Tthcse2, Tfucse2 (brown) and csa5.
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using the TLSMD web server.38,39 The structure was validated 
with MolProbity.40
Dynamic light scattering. DLS experiments were performed 
using a Zetasizer μV system (Malvern Instruments) with a quartz 
SUPRASIL® cuvette. The experiments were performed at room 
temperature and in triplicate. The data were analyzed using the 
Zetasizer software.
Please cite references 43–46 in the text or delete the reference. 
Also, please add a callout for Table 1 in the text.
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the antibodies then eluted with 100 mM triethylamine pH 11.5 
into 1 M Tris pH 8.0. The purified antibodies were dialyzed into 
PBS and then cross-linked to Protein G Sepharose (Sigma) by 
incubating together in TBS buffer followed by cross-linking with 
20 mM dimethyl pimelimidate in 0.2 M triethanolamine. The 
beads were washed with trithenaolamine and ethanolamine before 
incubation with S. solfataricus P1 cell lysate prepared as described 
previously.19 After overnight incubation at 4°C, the beads were 
washed with TBS and the bound protein eluted with sodium 
citrate pH 2.5. Samples were run on NuPAGE SDS-PAGE gels 
(Invitrogen) and blotted onto iBlot stacks (Invitrogen). The sam-
ples were blocked with 5% milk powder in PBS, 0.05% TWEEN 
for 1 h and then incubated with the primary antibody of choice. 
The blots were incubated with 1:10,000 Immunopure rabbit 
anti-goat HRP (Thermo Scientific) in PBS, 0.1% TWEEN for 
1 h and then visualized with SuperSignal West Pico kit (Pierce) 
according to the manufacturer’s instructions.
Fluorescence anisotropy. Synthetic oligonucleotides were 
purchased from Integrated DNA Technologies of fluorescently 
labeled crRNA from spacer 26 of CRISPR locus A of S. solfa-
taricus P1, non-labeled complementary target ssDNA with 
PAM sequence and fluorescently labeled non-target ssDNA (see 
Table S1 for sequences). crRNA and protospacer were mixed 1:1, 
heated at 80°C for 5 min and cooled slowly to form a hetero-
duplex. Fluorescence anisotropy measurements (λ
ex
 490 nm, λ
em
 
535 nm) were recorded using a Varian Cary Eclipse fluorescence 
spectrophotometer at room temperature. Protein solutions were 
titrated into 20 nM crRNA, 20 nM non-target ssDNA or 20 nM 
heteroduplex in 20 mM Tris pH 7.5, 150 mM NaCl, 5% glyc-
erol, 1 mM EDTA. Measurements were recorded over a range of 
protein concentrations (0.04 –11 μM). The data were analyzed 
using KaleidaGraph (Synergy Software) and, where appropriate, 
fitted to binding curves.
Crystallization of Sso1398. The selenomethionyl derivative 
of Sso1398 was crystallized at 2 mg ml-1 in vapor diffusion sit-
ting drop experiments at 20°C. The crystals grew in a condition 
of 1:1 protein-to-precipitant with a reservoir of 0.1 M sodium 
acetate pH 4.0, 0.23 M potassium chloride and 39% PEG500. 
The crystals were cryo-cooled in liquid nitrogen directly from 
the drop. A single-wavelength anomalous diffraction data set was 
collected at the Se-K absorption edge at 100 K on the microfocus 
beamline I24, Diamond Light Source. The data were processed 
with xia231 and the phases solved using Phenix AutoSolve.32 
The electron density map was further modified using Parrot33 
before chain tracing with Buccaneer,34 both as part of the CCP4 
suite.35 The chains were manually assigned followed by auto-
mated model building with Phenix AutoBuild.32 The model was 
refined by cycles of manual correction in COOT36 and refine-
ment with REFMACv5.637 using TLS constraints generated 
Table 1. Data collection and refinement statistics
Data  
collection
Sso1398SeMet Refinement Sso1398SeMet
Wavelength (Å) 0.98 Rwork/Rfree 0.20/0.22
space group c 1 2 1 Mean B-value (Å2)
a, b, c (Å) 285.0, 53.7, 216.7 All atoms 43
α, β, γ (°) 90.0, 124.7, 90.0 protein 43
Resolution (Å) 2.72 Water 26
I/σI 12.3 (2.3) peG 55
Rmerge 0.109 (0.814) Rmsd
completeness 100.0 (100.0) Bond lengths (Å) 0.01
Multiplicity 6.7 (7.0) Angles (°) 1.13
Anomalous 
completeness
99.5 (99.8)
Anomalous 
multiplicity
3.5 (3.6)
Data are presented as averages with statistics for the highest resolution 
shell in parentheses.
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